Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Hold
Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
- Latest
- Trending
Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
Discover the financial challenges facing Allego NV in the electric vehicle charging sector. Dive into the volatile stock performance, negative ...
Investors seeking a blend of growth, income, and value should consider Viking, Brookfield Renewable, and UPS. While UPS faced a ...
An 80-year-old woman's financial well-being is a concern as her health deteriorates. Analysts discuss the potential impact of the Trump ...
Delve into Diana Shipping Inc's recent financial report to uncover its resilient performance in the dynamic shipping sector. Find out ...
Investing in Indian IT stocks for the long term can be wise, as they remain in base-building mode. Consider quality ...
Lin and Bonner, directors of DCM International IV, sold shares between $27.18 and $27.97 on March 28, 2024. The lowest ...
Transactions on March 27, 2024, saw the sale of 2,184 shares of common stock by Benson, totaling $685,721. Benson retains ...
ChenGuang Biotech Group's share price has dropped 7.5% in the past three months. However, their ROE of 14% shows a ...
SA shares are up 25% YTD, raising $42.8M in 2023. With room for $67.6M in ATM offering, is it a ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.